Tumor markers in the diagnosis of malignant serous effusions

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 3, 1997, Pages 247-250

  Cascinu, Stefano ^a   Del Ferro, Elena ^b   Barbanti, Ilaro ^a   Ligi, Marco ^b   Fedeli, Anna ^b   Catalano, Giuseppina ^b  

^a SAN SALVATORE HOSPITAL   (Italy)

^b NONE

Author keywords

Serous effusions; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CYTODIAGNOSIS; COLON CARCINOMA; FEMALE; HUMAN; KIDNEY CARCINOMA; LIVER CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PERITONEUM EXUDATE; PLEURA EFFUSION; PROSTATE CARCINOMA; STOMACH CARCINOMA;

ADULT; AGED; ALPHA-FETOPROTEINS; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ASCITIC FLUID; CA-15-3 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PERICARDIAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PROSTATE-SPECIFIC ANTIGEN; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0030991228     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199706000-00007     Document Type: Article

References (18)

1. Ruckdeschel JC. Management of malignant pleural effusion: an overview. Semin Oncol 1988;15:24-8.
2. Dekker A, Bupp PA. Cytology of serous effusions: An investigation into the usefulness of cell blocks versus smears. Am J Clin Pathol 1978;70:855-60.
3. Colloredo Mels G, Bellati G, Auriemma L, et al. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the predictive of malignancy. Ital J Gastroenterol 1991;23:179-86.
4. Fergusson RJ, Fisken J, McIntyre MA, Roulston JE, Leonard RC. Measurement of placental alkaline phosphatase activity in benign and malignant pleural effusions. J Clin Pathol 1992;45: 1114-5.
5. Sarandakou A, Poulakis N, Phocas I, et al. Diagnostic value of soluble interleukin-2 receptors in pleural effusions. Anticancer Res 1990; 10:1437-8.
6. Ciardiello F, Lidereau R, Challahan R, et al. Transforming growth factor alpha (TG alpha) expression in breast and colon tumors and TGF alpha activity in the effusions of cancer patients. Proc Am Assoc Cancer Res 1989;30:895.
7. Ammon A, Eiffert H, Reil S, Beyer JH, Droese M, Hiddemann W. Tumor-associated antigens in effusions of malignant and benign origin. Clin Invest 1993;71:437-44.
8. Gerbes AL, Jungst D, Xie Y, Permanetter W, Paumgartner G. Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Cancer 1991;68:1808-14.
9. Tamura S, Nishigaki T, Moriwaki Y, et al. Tumor markers in pleural effusion diagnosis. Cancer 1988;61:298-302.
10. Martinez- Vea A, Gatell JM, Segura F, et al. Diagnostic value of tumoral markers in serous effusions. Cancer 1982;50:1783-8.
11. Couch WD. Combined effusions fluid tumor marker assay, carcinoembryonic antigen (CEA) and human chorionic gonadotropin (hCG), in the detection of malignant tumors. Cancer 1981;48:2475-9.
12. Glantz SA. Primer of biostatistics. New York: McGraw-Hill, 1992.
13. Salerno F, Restelli B, Incerti P, et al. Utility of ascitic fluid analysis in patients with malignancy-related ascites. Scand J Gastroenterol 1990;25:251-6.
14. Scagliotti GV, Gatti E, Michelotto F, Pozzi E. Neuron-specific enolase in exudative pleural effusions. J Tumor Markers Oncol 1990;5:373-7.
15. Kandylis K, Vassilomanolakis M, Baziotis N, et al. Diagnostic significance of the tumor markers CEA, CA 15.3 and CA 125 in malignant effusions in breast cancer. Ann Oncol 1990; 1:435-8.
16. Lindgren J, Kuusela P, Hellstrom PE, Petterson T, Klockars M. The ovarian cancer associated antigen CA 125 in patients with pleural effusion. Eur J Cancer Clin Oncol 1988;24: 737-9.
17. Mezger J, Permanette W, Gerbes AL, Wilmans W, Lamerz R. Tumor associated antigens in the diagnosis of serous effusions. J Clin Pathol 1988;41:633-43.
18. Kabawat SE, Bast RC, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC 125. Int J Gynecol Pathol 1983;2:275-85.